A leading obesity doctor has said a new trial of weight loss drugs Mounjaro and Wegovy may lead advertisers to reconsider their prices.

Two blockbuster weight-loss drugs just went head-to-head — and the results are stunning. In a major new trial, Mounjaro ...

In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

KATHRYN Thomas has opened up about her “amazing” new job and told fans to “watch this space” for what’s coming next. The radio star joined Six O’Clock Show ...

Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...

Zaina Jasser urges patients and medical practitioners to be cautious of the moral and sociological implications of ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

Trump shared the anecdote as he signed an order Monday intended to drastically reduce the price Americans pay for ...

President Donald Trump signed an executive order on Monday aimed at slashing prescription drug prices in the U.S. that could ...

Mounjaro and Wegovy are two of the biggest names in the world of weight-loss drugs but it's been unclear which is more ...

The effects they have on your body and mind vary, as Wegovy flips one appetite switch in your brain, while Mounjaro flips two ...